This inventor holds 1 USPTO granted patent. Top assignee: Genzyme Corporation. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: The Innovations of Francois Binette
Introduction
Francois Binette is an accomplished inventor based in Belmont, California. He has made significant contributions to the field of cell culture, particularly in the development of serum-free media formulations. His work has implications for the cultivation of chondrocytes, which are essential for cartilage repair and regeneration.
Latest Patents
Francois Binette holds a patent for "Chondrocyte media formulations and culture procedures." This invention focuses on creating a serum-free defined cell culture medium that includes a supplement mixture, a component mixture, a vitamin mixture, an inorganic salt mixture, and an amino acid mixture. The defined medium is particularly useful for culturing fibroblasts, especially chondrocytes. Additionally, the patent claims methods for enhancing the differentiation of chondrocytes and promoting the synthesis of a cartilage-specific matrix using tumor growth factor beta (TGF-β).
Career Highlights
Francois Binette has worked at Genzyme Corporation, where he has been involved in innovative research and development. His expertise in cell culture and regenerative medicine has positioned him as a valuable asset in the biotechnology industry. His contributions have the potential to advance therapeutic approaches for cartilage-related conditions.
Collaborations
Francois has collaborated with notable colleagues, including Marie E. Brown and John M. McPherson. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Francois Binette's work exemplifies the importance of innovation in the field of biotechnology. His patent on chondrocyte media formulations highlights his commitment to advancing medical science and improving patient outcomes. His contributions continue to influence the landscape of regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
